Cargando...
Therapeutic Potential of Fluoxetine in Neurological Disorders
The selective serotonin reuptake inhibitor (SSRI) fluoxetine, which is registered for a variety of psychiatric disorders, has been found to stimulate the cAMP‐responsive element binding protein (CREB), increase the production of brain‐derived neurotrophic factor (BNDF) and the neurotrophic peptide S...
Gardado en:
| Publicado en: | CNS Neurosci Ther |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Blackwell Publishing Inc
2008
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494017/ https://ncbi.nlm.nih.gov/pubmed/18482027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2008.00040.x |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|